- Home
- / Hangzhou Alltest Biotech
Hangzhou Alltest Biotech
Stock Price
¥67.8
2024-10-29
Market Capitalization
¥5.3 B
2024-10-29
Revenue
¥745.2 M
FY, 2023
Hangzhou Alltest Biotech Summary
Company Summary
- Overview
- Hangzhou Alltest Biotech (杭州奥泰生物科技有限公司) is a company that manufactures and sells in vitro diagnostic (IVD) products. It offers antigen and fluorescence immunoassay tests, lateral flow (LF) readers, blood glucose monitoring systems, virus specimen stabilizers, hemoglobin test meter products, etc.
- Type
- Public
- Status
- Active
- Founded
- 2009
- HQ
- Hang Zhou Shi, CN | view all locations
- Website
- https://www.alltests.com.cn/
- Cybersecurity rating
Table of Contents
Hangzhou Alltest Biotech Financials
Summary Financials
- Revenue (Q1, 2024)
- ¥197.9M
- Gross profit (Q1, 2024)
- ¥98.2M
- Net income (Q1, 2024)
- ¥44.6M
- Cash (Q1, 2024)
- ¥1.2B
- EBIT (Q1, 2024)
- ¥37.9M
- Enterprise value
- $4.1B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2025